Literature DB >> 2819073

The CYP2D gene subfamily: analysis of the molecular basis of the debrisoquine 4-hydroxylase deficiency in DA rats.

E Matsunaga1, U M Zanger, J P Hardwick, H V Gelboin, U A Meyer, F J Gonzalez.   

Abstract

The DA rat has been proposed as an animal model for the human debrisoquine 4-hydroxylase/bufuralol 1'-hydroxylase genetic deficiency. To determine the mechanism of this deficiency, we isolated and sequenced five cDNAs in the CYP2D gene subfamily including a new IID1 allele and two cDNAs of novel P450s, designated IID3 and IID5. IID3 and IID5 cDNA-deduced amino acid sequences contained 500 and 504 residues with calculated molecular weights of 56,683 and 57,081, respectively. IID5 displayed 20 amino acid differences with the IID1, yet bore only 72% and 76% similarity to IID2 and IID3. Despite an overall nucleotide similarity of 80-98% between the 4 cDNAs, a region of 134 nucleotides of sequence exists that contains only 1 base difference. This region is probably the result of gene conversion events between the P450 IID genes. Although all IID cDNAs were expressed into immunodetectable proteins using the COS cell SV40-based expression system, only IID1 could effectively catalyze the oxidation of the prototype substrate bufuralol. Expression of a cDNA isolated in an earlier study [Gonzalez, F. J., Matsunaga, T., Nagata, K., Meyer, U. A., Nebert, D. W., Pastewka, J., Kozak, C. A., Gillette, J., Gelboin, H. V., & Hardwick, J. P. (1987) DNA 6, 149-161], previously called db1 and now designated IID1v, produced a protein with a drastically reduced activity as compared to cDNA-expressed IID1 despite only four amino acid differences between the two cDNA-deduced protein sequences.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2819073     DOI: 10.1021/bi00444a030

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Rat CYP2D2, not 2D1, is functionally conserved with human CYP2D6 in endogenous morphine formation.

Authors:  Nadja Grobe; Toni M Kutchan; Meinhart H Zenk
Journal:  FEBS Lett       Date:  2012-05-26       Impact factor: 4.124

2.  The rat P450 IID subfamily: complete sequences of four closely linked genes and evidence that gene conversions maintained sequence homogeneity at the heme-binding region of the cytochrome P450 active site.

Authors:  E Matsunaga; M Umeno; F J Gonzalez
Journal:  J Mol Evol       Date:  1990-02       Impact factor: 2.395

3.  Repression of multiple CYP2D genes in mouse primary hepatocytes with a single siRNA construct.

Authors:  Omaima Elraghy; William S Baldwin
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-08-15       Impact factor: 2.416

Review 4.  The role of monoamines in the changes in body temperature induced by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its derivatives.

Authors:  J R Docherty; A R Green
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

Review 5.  Development and Uses of Offline and Web-Searchable Metabolism Databases - The Case of Benzo[a]pyrene.

Authors:  Slobodan P Rendic; Frederick P Guengerich
Journal:  Curr Drug Metab       Date:  2018       Impact factor: 3.731

6.  Molecular characterization of lengthy mitochondrial DNA duplications from the parasitic nematode Romanomermis culicivorax.

Authors:  J L Azevedo; B C Hyman
Journal:  Genetics       Date:  1993-04       Impact factor: 4.562

7.  The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype.

Authors:  M I Colado; J L Williams; A R Green
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

8.  Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibility.

Authors:  A K Daly; S Cholerton; M Armstrong; J R Idle
Journal:  Environ Health Perspect       Date:  1994-11       Impact factor: 9.031

9.  Functional phenotyping of the CYP2D6 probe drug codeine in the horse.

Authors:  S R Gretler; C J Finno; P H Kass; H K Knych
Journal:  BMC Vet Res       Date:  2021-02-13       Impact factor: 2.741

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.